Lotus Pharmaceuticals (LTUS) has announced a significant Land Development Deal as detailed by President Georgene Rivers. The company is nearing a Letter of Intent and plans to release further details soon. This move signifies potential growth in the company's real estate or operational capacity, which could positively affect future revenues. However, forward-looking statements suggest uncertainties in executing these plans due to various economic risks and regulatory changes.
Lotus Pharmaceuticals, Inc. (LTUS) announced its achievement of Current, Green-Light Status with OTC MARKETS, confirming compliance with all legal and financial requirements. President Georgene Rivers expressed enthusiasm about the company's future prospects, emphasizing that this status provides shareholders with essential information for investment decisions. However, the company cautioned that forward-looking statements could be affected by various risks and uncertainties that may influence actual results.